Doug Schenkel
Stock Analyst at Wolfe Research
(2.84)
# 1,594
Out of 5,154 analysts
70
Total ratings
50%
Success rate
31.95%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Upgrades: Outperform | $60 | $36.68 | +63.58% | 3 | Dec 10, 2025 | |
| WAT Waters | Upgrades: Outperform | $480 | $302.54 | +58.66% | 2 | Dec 10, 2025 | |
| GH Guardant Health | Upgrades: Outperform | $75 | $91.20 | -17.76% | 3 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Initiates: Outperform | $32 | $18.59 | +72.14% | 1 | Jul 14, 2025 | |
| TEM Tempus AI | Initiates: Outperform | $60 | $52.26 | +14.81% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $75.74 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $46.94 | +27.82% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $15.41 | +81.70% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $245.86 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $119.99 | - | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $3.55 | - | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $285 | $195.50 | +45.78% | 2 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $115.07 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $49 | $44.55 | +10.10% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $20.81 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $124.62 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $103.50 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $501.97 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.15 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $91.34 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.38 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $8.17 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $198.13 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.35 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $2.38 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.93 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.26 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.78 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $22.25 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $1.23 | +1,363.41% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $21.14 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $237.01 | -62.03% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.06 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $165.22 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $68.10 | -76.51% | 2 | Sep 28, 2017 |
Bruker
Dec 10, 2025
Upgrades: Outperform
Price Target: $60
Current: $36.68
Upside: +63.58%
Waters
Dec 10, 2025
Upgrades: Outperform
Price Target: $480
Current: $302.54
Upside: +58.66%
Guardant Health
Sep 25, 2025
Upgrades: Outperform
Price Target: $75
Current: $91.20
Upside: -17.76%
Caris Life Sciences
Jul 14, 2025
Initiates: Outperform
Price Target: $32
Current: $18.59
Upside: +72.14%
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $52.26
Upside: +14.81%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $75.74
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $46.94
Upside: +27.82%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $15.41
Upside: +81.70%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $245.86
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $119.99
Upside: -
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $3.55
Upside: -
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $195.50
Upside: +45.78%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $115.07
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $49
Current: $44.55
Upside: +10.10%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $20.81
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $124.62
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $103.50
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $501.97
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $5.15
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $91.34
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.38
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $8.17
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $198.13
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.35
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $2.38
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.93
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $6.26
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.78
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $22.25
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $1.23
Upside: +1,363.41%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $21.14
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $237.01
Upside: -62.03%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $5.06
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $165.22
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $68.10
Upside: -76.51%